363 related articles for article (PubMed ID: 25993694)
21. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
[TBL] [Abstract][Full Text] [Related]
22. Limited clinical significance of tissue calprotectin levels in bowel mucosa for the prediction of complicated course of the disease in children with ulcerative colitis.
Fabian O; Hradsky O; Lerchova T; Mikus F; Zamecnik J; Bronsky J
Pathol Res Pract; 2019 Dec; 215(12):152689. PubMed ID: 31679791
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level.
Peterson CG; Lampinen M; Hansson T; Lidén M; Hällgren R; Carlson M
Scand J Clin Lab Invest; 2016 Sep; 76(5):393-401. PubMed ID: 27223407
[TBL] [Abstract][Full Text] [Related]
24. Oral delivery of staphylococcal nuclease ameliorates DSS induced ulcerative colitis in mice via degrading intestinal neutrophil extracellular traps.
Dong W; Liu D; Zhang T; You Q; Huang F; Wu J
Ecotoxicol Environ Saf; 2021 Jun; 215():112161. PubMed ID: 33812202
[TBL] [Abstract][Full Text] [Related]
25. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
[TBL] [Abstract][Full Text] [Related]
26. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
27. Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.
Yamamoto T; Shiraki M; Bamba T; Umegae S; Matsumoto K
Int J Colorectal Dis; 2014 Apr; 29(4):485-91. PubMed ID: 24343276
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
Magro F; Lopes S; Coelho R; Cotter J; Dias de Castro F; Tavares de Sousa H; Salgado M; Andrade P; Vieira AI; Figueiredo P; Caldeira P; Sousa A; Duarte MA; Ávila F; Silva J; Moleiro J; Mendes S; Giestas S; Ministro P; Sousa P; Gonçalves R; Gonçalves B; Oliveira A; Chagas C; Torres J; Dias CC; Lopes J; Borralho P; Afonso J; Geboes K; Carneiro F;
J Crohns Colitis; 2017 Apr; 11(4):435-444. PubMed ID: 27664275
[TBL] [Abstract][Full Text] [Related]
29. Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease.
Pinto-Lopes P; Melo F; Afonso J; Pinto-Lopes R; Rocha C; Melo D; Macedo G; Dias CC; Carneiro F; Magro F;
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00320. PubMed ID: 33704099
[TBL] [Abstract][Full Text] [Related]
30. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
[TBL] [Abstract][Full Text] [Related]
31. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
Brandse JF; Bennink RJ; van Eeden S; Löwenberg M; van den Brink GR; DʼHaens GR
Inflamm Bowel Dis; 2016 Jun; 22(6):1384-90. PubMed ID: 26978724
[TBL] [Abstract][Full Text] [Related]
32. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.
Gisbert JP; Bermejo F; Pérez-Calle JL; Taxonera C; Vera I; McNicholl AG; Algaba A; López P; López-Palacios N; Calvo M; González-Lama Y; Carneros JA; Velasco M; Maté J
Inflamm Bowel Dis; 2009 Aug; 15(8):1190-8. PubMed ID: 19291780
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
34. The Anti-inflammatory Immune Regulation Induced by Butyrate Is Impaired in Inflamed Intestinal Mucosa from Patients with Ulcerative Colitis.
Magnusson MK; Isaksson S; Öhman L
Inflammation; 2020 Apr; 43(2):507-517. PubMed ID: 31797122
[TBL] [Abstract][Full Text] [Related]
35. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis.
Wenzel UA; Magnusson MK; Rydström A; Jonstrand C; Hengst J; Johansson ME; Velcich A; Öhman L; Strid H; Sjövall H; Hansson GC; Wick MJ
PLoS One; 2014; 9(6):e100217. PubMed ID: 24945909
[TBL] [Abstract][Full Text] [Related]
37. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease.
Li G; Lin J; Zhang C; Gao H; Lu H; Gao X; Zhu R; Li Z; Li M; Liu Z
Gut Microbes; 2021; 13(1):1968257. PubMed ID: 34494943
[TBL] [Abstract][Full Text] [Related]
38. Review article: faecal calprotectin and histologic remission in ulcerative colitis.
D'Amico F; Bonovas S; Danese S; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2020 Apr; 51(7):689-698. PubMed ID: 32048751
[TBL] [Abstract][Full Text] [Related]
39. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
[TBL] [Abstract][Full Text] [Related]
40. Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy.
Magro F; Alves C; Lopes J; Lopes S; Tavares de Sousa H; Cotter J; Macedo da Silva V; Lago P; Vieira A; Brito M; Duarte MAM; Portela F; Silva JP; Ministro P; Arroja B; Carvalho L; Torres J; Santiago M; Estevinho MM; Danese S; Peyrin-Biroulet L; Dias CC; Borralho P; Feakins RM; Carneiro F
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2567-2576.e9. PubMed ID: 32920215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
